CombiMatrix Molecular Diagnostics Establishes A Facility In The State-Of-The-Art MaRS Discovery District In Toronto, Ontario, Canada

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--April 10, 2006--Acacia Research Corporation (Nasdaq:CBMX - News; Nasdaq:ACTG - News) announced today that its CombiMatrix group's wholly-owned subsidiary CombiMatrix Molecular Diagnostics (CMDX) has established a new facility in the world-class MaRS Discovery District in downtown Toronto.
MORE ON THIS TOPIC